Maristela Mitiko Okamoto

Dr. Maristela Mitiko Okamoto

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
NLNatalia M Leguisamo
Natalia M Leguisamo
ALAlexandre M Lehnen
Alexandre M Lehnen
UMUbiratan Machado
Ubiratan Machado
MOMaristela Mitiko Okamoto
Maristela Mitiko Okamoto
MMMelissa M Markoski
Melissa M Markoski
BSBeatriz Schaan
Beatriz Schaan
Background: Metabolic syndrome is characterized by insulin resistance, which is closely related to GLUT4 content in insulin-sensitive tissues. Thus, we evaluated the GLUT4 expression, insulin resistance and inflammation, characteristics of the metabolic syndrome, in an experimental model. Methods: Spontaneously hypertensive neonate rats (18/group) were treated with monosodium glutamate (MetS) during 9 days, and compared with Wistar-Kyoto (C) and saline-treated SHR (H). Blood pressure (BP) and lipid levels, C-reactive protein (CRP), interleukin 6 (IL-6), TNF-α and adiponectin were evaluated. GLUT4 protein was analysed in the heart, white adipose tissue and gastrocnemius. Studies were performed at 3 (3-mo), 6 (6-mo) and 9 (9-mo) months of age. Results: MetS rats were more insulin resistant (p<0.001, all ages) and had higher BP (3-mo: p<0.001, 6-mo: p = 0.001, 9-mo: p = 0.015) as compared to C. At 6 months, CRP, IL-6 and TNF-α were higher (p<0.001, all comparisons) in MetS rats vs H, but adiponectin was lower in MetS at 9 months (MetS: 32 ± 2, H: 42 ± 2, C: 45 ± 2 pg/mL; p<0.001). GLUT4 protein was reduced in MetS as compared to C rats at 3, 6 and 9-mo, respectively (Heart: 54%, 50% and 57%; Gastrocnemius: 37%, 56% and 50%; Adipose tissue: 69%, 61% and 69%). Conclusions: MSG-treated SHR presented all metabolic syndrome characteristics, as well as reduced GLUT4 content, which must play a key role in the impaired glycemic homeostasis of the metabolic syndrome.

11 July 2011 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
MOMaristela Mitiko Okamoto
Maristela Mitiko Okamoto
GAGabriel Anhe
Gabriel Anhe
RSRobinson Sabino-Silva
Robinson Sabino-Silva
MMMilano Felipe dos Santos Ferreira Marques
Milano Felipe dos Santos Ferreira Marques
HFHelayne Soares Freitas
Helayne Soares Freitas
UMUbiratan Fabres Machado
Ubiratan Fabres Machado
Insulin replacement is the only effective therapy to manage hyperglycemia in type 1 diabetes mellitus (T1DM). Nevertheless, intensive insulin therapy has inadvertently led to insulin resistance. This study investigates mechanisms involved in the insulin resistance induced by hyperinsulinization. Wistar rats were rendered diabetic by alloxan injection, and 2 weeks later received saline or different doses of neutral protamine Hagedorn insulin (1.5, 3, 6, and 9 U/day) over 7 days. Insulinopenic-untreated rats and 6U- and 9U-treated rats developed insulin resistance, whereas 3U-treated rats revealed the highest grade of insulin sensitivity, but did not achieve good glycemic control as 6U- and 9U-treated rats did. This insulin sensitivity profile was in agreement with glucose transporter 4 expression and translocation in skeletal muscle, and insulin signaling, phosphoenolpyruvate carboxykinase/glucose-6-phosphatase expression and glycogen storage in the liver. Under the expectation that insulin resistance develops in hyperinsulinized diabetic patients, we believe insulin sensitizer approaches should be considered in treating T1DM.

29 June 2016 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
CYCaio Yogi Yonamine
Caio Yogi Yonamine
Erika Pinheiro MachadoErika Pinheiro Machado
Erika Pinheiro Machado
MMMaria Luiza Estimo Michalani
Maria Luiza Estimo Michalani
HFHelayne Soares Freitas
Helayne Soares Freitas
MOMaristela Mitiko Okamoto
Maristela Mitiko Okamoto
UMUbiratan Machado
Ubiratan Machado
Resveratrol is a natural polyphenol that has been proposed to improve glycemic control in diabetes, by mechanisms that involve improvement in insulin secretion and activity. In type 1 diabetes (T1D), in which insulin therapy is obligatory, resveratrol treatment has never been investigated. The present study aimed to evaluate resveratrol as an adjunctive agent to insulin therapy in a T1D-like experimental model. Rats were rendered diabetic by streptozotocin (STZ) treatment. Twenty days later, four groups of animals were studied: non-diabetic (ND); diabetic treated with placebo (DP); diabetic treated with insulin (DI) and diabetic treated with insulin plus resveratrol (DIR). After 30 days of treatment, 24-hour urine was collected; then, blood, soleus muscle, proximal small intestine, renal cortex and liver were sampled. Specific glucose transporter proteins were analyzed (Western blotting) in each territory of interest. Solute carrier family 2 member 2 (Slc2a2), phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase catalytic subunit (G6pc) mRNAs (qPCR), glycogen storage and sirtuin 1 (SIRT1) activity were analyzed in liver. Diabetes induction increased blood glucose, plasma fructosamine concentrations, and glycosuria. Insulin therapy partially recovered the glycemic control; however, resveratrol as adjunctive therapy additionally improved glycemic control and restored plasma fructosamine concentration to values of non-diabetic rats. Resveratrol did not alter the expression of the glucose transporters GLUT2 and SGLT1 in the intestine, GLUT2 and SGLT2 in kidney and GLUT4 in soleus, suggesting that fluxes of glucose in these territories were unaltered. Differently, in liver, resveratrol promoted a reduction in Slc2a2, Pck1, and G6pc mRNAs, as well as in GLUT2 protein (P < 0.05, DIR vs. DI); besides, it increased (P < 0.01, DIR vs. DI) the hepatic glycogen content, and SIRT1 protein. Resveratrol is able to improve glycemic control in insulin-treated T1D-like rats. This effect seems not to involve changes in glucose fluxes in the small intestine, renal proximal tubule, and soleus skeletal muscle; but to be related to several changes in the liver, where downregulation of Slc2a2/GLUT2, Pck1, and G6pc expression was observed, favoring reduction of glucose production and efflux. Besides, resveratrol increased SIRT1 nuclear protein content in liver, which may be related to the observed gene expression regulations.

24 October 2013 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
RSRobinson Sabino-Silva
Robinson Sabino-Silva
MOMaristela Mitiko Okamoto
Maristela Mitiko Okamoto
ADAline David-Silva
Aline David-Silva
RMRosana Cristina Mori
Rosana Cristina Mori
HFHelayne Soares Freitas
Helayne Soares Freitas
UMUbiratan Machado
Ubiratan Machado
Oral health complications in diabetes and hypertension include decreased salivary secretion. The sodium-glucose cotransporter 1 (SGLT1) protein, which transports 1 glucose/2 Na+/264 H2O molecules, is described in salivary glands. We hypothesized that changes in SGLT1 expression in the luminal membrane of ductal cell may be related to an altered salivary flow.

Verified
Journal Article
Open access
PDF file
SASayonara Ivana Santos de Assis
Sayonara Ivana Santos de Assis
LALeonardo Szalo Amendola
Leonardo Szalo Amendola
MOMaristela Mitiko Okamoto
Maristela Mitiko Okamoto
GFGuilherme da Silva Ferreira
Guilherme da Silva Ferreira
RIRodrigo Tallada Iborra
Rodrigo Tallada Iborra
Marisa PassarelliMarisa Passarelli
Marisa Passarelli
Advanced glycation end products (AGEs) prime macrophages for lipopolysaccharide (LPS)-induced inflammation. We investigated the persistence of cellular AGE-sensitization to LPS, considering the nuclear content of p50 and p65 nuclear factor kappa B (NFKB) subunits and the expression of inflammatory genes. Macrophages treated with control (C) or AGE-albumin were rested for varying intervals in medium alone before being incubated with LPS. Comparisons were made using one-way ANOVA or Student t-test (n = 6). AGE-albumin primed macrophages for increased responsiveness to LPS, resulting in elevated levels of TNF, IL-6, and IL-1beta (1.5%, 9.4%, and 5.6%, respectively), compared to C-albumin. TNF, IL-6, and IL-1 beta secretion persisted for up to 24 h even after the removal of AGE-albumin (area under the curve greater by 1.6, 16, and 5.2 times, respectively). The expressions of Il6 and RelA were higher 8 h after albumin removal, and Il6 and Abca1 were higher 24 h after albumin removal. The nuclear content of p50 remained similar, but p65 showed a sustained increase (2.9 times) for up to 24 h in AGE-albumin-treated cells. The prolonged activation of the p65 subunit of NFKB contributes to the persistent effect of AGEs on macrophage inflammatory priming, which could be targeted for therapies to prevent complications based on the AGE–RAGE–NFKB axis.

1 March 2016 in Life Sciences
Verified
Journal Article
Closed access
MMMaria Sara de Lima Coutinho Mattera
Maria Sara de Lima Coutinho Mattera
FCFernando Yamamoto Chiba
Fernando Yamamoto Chiba
MMMax Sander de Oliveira da Mota
Max Sander de Oliveira da Mota
RPRenato Felipe Pereira
Renato Felipe Pereira
Edilson ErvolinoEdilson Ervolino
Edilson Ervolino
DSDoris Hissako Sumida
Doris Hissako Sumida